Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
85,050,694
-
Share change
-
+5,189,120
-
Total reported value
-
$3,682,149,679
-
Put/Call ratio
-
106%
-
Price per share
-
$43.30
-
Number of holders
-
214
-
Value change
-
+$238,897,265
-
Number of buys
-
103
-
Number of sells
-
112
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q1 2017
As of 31 Mar 2017,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,050,694 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JANUS CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, FRANKLIN RESOURCES INC, Invesco Ltd., and STATE STREET CORP.
This page lists
214
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.